ロード中...
Defining the Complement Biomarker Profile of C3 Glomerulopathy
BACKGROUND AND OBJECTIVES: C3 glomerulopathy (C3G) applies to a group of renal diseases defined by a specific renal biopsy finding: a dominant pattern of C3 fragment deposition on immunofluorescence. The primary pathogenic mechanism involves abnormal control of the alternative complement pathway, al...
保存先:
| 出版年: | Clin J Am Soc Nephrol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Nephrology
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4220750/ https://ncbi.nlm.nih.gov/pubmed/25341722 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.01820214 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|